Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (8971)	3/7/1999 4:08:00 PM
From: sol dude	Respond to of 17367

George, spoke to Ellen this week. Costello has been in europe this week and is going to Japan this coming week. Probably no DSMB meeting till he is back provided mortality hit. (my opinion) Test his still blinded. He is out looking for collaborations on i-prex, mycoprex. Still waiting to hear from gne, vibes good. Company to work as fast as possible once trial is stopped along with fda to get drug approved for next meningo season. Trip to europe possible source for Bayer rumor. (my opinion) 700 enrolled in hem trial looking for prelim look at 800 patients Must keep the faith soldude

To: aknahow who wrote (8971)	3/7/1999 6:23:00 PM
From: Edscharp	Read Replies (1) \| Respond to of 17367

Sometimes, if you ask, you do receive. This is an e-mail I received from Xoma. Dear Mr. Schnaper: There is no news item (or anything else) to explain the recent downturn of the stock. If it comforts you at all, many other NASDAQ stocks experienced the same downturn at the same time as XOMA. Please call Ellen Martin, Director of Corporate Communications, to discuss further or to get a company update (same number, below). Whenever we issue a news release, you may find it promptly on our website: xoma.com. If you would like, I'd be happy to place you on our fax distribution list for News Releases. Regards, Jennifer Doyle Corporate Communications XOMA Ltd. doyle@xoma.com 510-644-1170 ext. 2026 510-649-0315 fax